BCL2L2 and urinary bladder cancer: We decided to add also one fusion transcript (BCL2L2-PABPN1) to the list, which naturally occurs as a product of read-through transcription of BCL2L2 and its neighboring gene, PABPN1. This chimeric RNA was shown to be overexpressed in bladder cancer [53].